<p>Specific study characteristics and the number of studies that possess each characteristic.</p><p>Characteristics of eligible studies (n = 17).</p
<p>Demographic and clinical characteristics of the study population (n = 34).</p
<p>Clinical Characteristics of the study population at admission, by study groups.</p
Characteristics of the included studies, including types, duration, frequency of intervention and ou...
<p>Main characteristics of the eligible studies included in the systematic review.</p
<p>Study characteristics related to number of participants, inclusion and exclusion criteria.</p
<p>Socio-demographic characteristics of the participants from the eligible studies.</p
<p><i>IHC</i> Immunohistochemistry.</p><p>Characteristics of eligible studies.</p
<p>Socio-demographic and individual characteristics of study participants (N = 497).</p
<p>General characteristics of the total study population, and by gender (N = 3181).</p
<p>Characteristics of studies included in the systematic review (n = 24 studies).</p
Summary showing characteristics of all eligible studies included in this review (N = 144).</p
<p>PB: population-based; HB: hospital-based; a: studies with P<sub>HWE</sub>>0.05; b: studies with P...
<p>Characteristics of the demographic and clinical characteristics of the study population (N = 5189...
<p>Characteristics of the selected studies, challenges, barriers, and efforts to address them.</p
<p>The Principal Characteristics of 21 Eligible Studies Included in the Meta-Analysis.</p
<p>Demographic and clinical characteristics of the study population (n = 34).</p
<p>Clinical Characteristics of the study population at admission, by study groups.</p
Characteristics of the included studies, including types, duration, frequency of intervention and ou...
<p>Main characteristics of the eligible studies included in the systematic review.</p
<p>Study characteristics related to number of participants, inclusion and exclusion criteria.</p
<p>Socio-demographic characteristics of the participants from the eligible studies.</p
<p><i>IHC</i> Immunohistochemistry.</p><p>Characteristics of eligible studies.</p
<p>Socio-demographic and individual characteristics of study participants (N = 497).</p
<p>General characteristics of the total study population, and by gender (N = 3181).</p
<p>Characteristics of studies included in the systematic review (n = 24 studies).</p
Summary showing characteristics of all eligible studies included in this review (N = 144).</p
<p>PB: population-based; HB: hospital-based; a: studies with P<sub>HWE</sub>>0.05; b: studies with P...
<p>Characteristics of the demographic and clinical characteristics of the study population (N = 5189...
<p>Characteristics of the selected studies, challenges, barriers, and efforts to address them.</p
<p>The Principal Characteristics of 21 Eligible Studies Included in the Meta-Analysis.</p
<p>Demographic and clinical characteristics of the study population (n = 34).</p
<p>Clinical Characteristics of the study population at admission, by study groups.</p
Characteristics of the included studies, including types, duration, frequency of intervention and ou...
DOI
Add to ORKG